<DOC>
	<DOCNO>NCT01193049</DOCNO>
	<brief_summary>The purpose study evaluate relationship upper low airway allergen-induced cytokine response mild asthmatic attempt demonstrate following : 1 ) positive correlation allergen-induced Type 2 T-helper cell ( Th2 ) cytokine ( interleukins 5 13 ) sputum nasal exudate ; 2 ) positive correlation effect prednisone versus placebo Th2 cytokine sputum nasal exudate .</brief_summary>
	<brief_title>A Study Effects Single Dose Prednisone Biomarkers Allergen Responses Asthmatics ( MK-0000-175 )</brief_title>
	<detailed_description />
	<mesh_term>Prednisone</mesh_term>
	<criteria>Has clinical history mild moderate asthma least 6 month , otherwise good health Participant allergic rhinitis asthma history nonseasonal airway symptom response aeroallergens OR seasonal symptom evaluate outofseason Is clinically stable free respiratory infection change allergen exposure least 4 week prior start study Has intolerance study drug , inhale salbutamol , antihistamine , potential asthma/anaphylaxis rescue medication Has intolerance lidocaine/lignocaine , sedative , atropine glycopyrrolate , medication associate bronchoscopy Has take oral parenteral corticosteroid within 8 week inhale corticosteroids/nasal corticosteroid within 5 week screen and/or study Has recent ( 4 week ) ongoing upper low respiratory tract infection Has active allergic rhinitis screening Has receive vaccination within 3 week screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Nasal Allergen Challenge , Inhaled Allergen Challenge , Asthma</keyword>
</DOC>